First peptide therapy appointment

What to expect at your first online peptide therapy appointment

A patient-safe guide to the first online peptide therapy visit: intake questions, clinician review, product-specific screening, prescription decisions, pharmacy sourcing, costs, and follow-up.

First-visit flow

1

Start with goals and symptoms: weight, energy, skin, hair, sexual health, recovery, focus, sleep, or longevity concerns.

2

Share medical history, medications, supplements, allergies, recent labs, pregnancy plans, and prior treatment response.

3

Discuss product fit across listed options such as GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, or methylene blue.

4

Confirm prescription status, pharmacy sourcing, pricing, instructions, side-effect plan, follow-up, and refill review before starting.

Direct answer

Your first online peptide therapy appointment should review your goals, health history, medications, allergies, labs, pregnancy considerations, and product fit before any prescription decision. A responsible clinic explains benefits and risks, confirms pharmacy sourcing and costs, and sets follow-up expectations. It should not guarantee treatment or sell research-use peptides for human use.

Before clinician review

The appointment should begin with your goal, not a cart

A first visit is not simply a checkout step. The clinician needs enough context to decide whether online peptide therapy is appropriate, whether a listed product fits the goal, and whether another medical evaluation is safer before treatment. Bring practical details, not just a desired medication name.

  • Prepare your main goal, timeline, prior attempts, and what would make treatment feel unsafe or unsuccessful.
  • List diagnoses, surgeries, allergies, current prescriptions, supplements, recent side effects, and medication changes.
  • Upload recent labs or records if they relate to weight, diabetes risk, hormones, fatigue, kidney or liver history, sleep, or cardiovascular risk.

Product-specific screening

Expect different questions for different peptide categories

Therapies listed on Peptide12 are not interchangeable. GLP-1 medicines raise different questions than sermorelin, PT-141, NAD+, glutathione, GHK-Cu topical foam, or low-dose oral methylene blue. The first appointment should connect the product category to your history, medications, risks, and realistic goals.

  • GLP-1 care may involve weight, diabetes history, gastrointestinal symptoms, pregnancy plans, pancreatitis, gallbladder, kidney, and thyroid-history questions.
  • Methylene blue requires careful medication-list review because serotonergic drugs and G6PD deficiency can change safety decisions.
  • PT-141, sermorelin, NAD+, glutathione, and topical GHK-Cu each need their own contraindication, side-effect, route, and follow-up discussion.

After the visit

A safe first appointment ends with next steps and boundaries

If treatment is appropriate, patients should understand what was prescribed, whether the product is FDA-approved, compounded, off-label, or evidence-limited for the goal, who dispenses it, what the full cost includes, and how follow-up works. If the clinician needs labs, records, or in-person care first, that is part of responsible care.

  • Ask which pharmacy or manufacturer is involved, what labels and storage instructions come with medication, and how shipping issues are handled.
  • Clarify total cost, membership or financing terms, supplies, labs, follow-up, refill review, and cancellation rules before paying.
  • Know who to contact for side effects, missed doses, dose questions, refill delays, worsening symptoms, or urgent warning signs.

Patient safety checklist

What to have ready for a first peptide visit

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

A clear goal and the symptoms, measurements, or baseline you want to track with your clinician.

Current prescriptions, over-the-counter medicines, supplements, allergies, and recent medication changes.

Medical history that could change product fit, including pregnancy plans, heart, kidney, liver, thyroid, diabetes, blood pressure, sleep, mood, or autoimmune history.

Recent labs or outside records if they are relevant to the concern or requested by the clinic.

Questions about FDA-approved versus compounded status, pharmacy sourcing, labels, storage, cost, follow-up, and refills.

Red-flag awareness: no-prescription sales, research-use peptides, guaranteed outcomes, hidden pharmacy sourcing, or pressure to buy immediately.

FAQs

Short answers for patients

What happens at a first online peptide therapy appointment?

A clinician or care team should review your goals, health history, medication list, allergies, labs or records when relevant, product-specific risks, pharmacy sourcing, cost, follow-up, and whether treatment is appropriate. A prescription is not guaranteed.

Can I get prescribed peptide therapy at the first visit?

Sometimes, but only if a licensed clinician has enough information and determines that treatment is clinically appropriate and legally available. Some patients need labs, records, medication changes, in-person evaluation, or a different care path before any prescription.

What should I prepare before my first peptide therapy visit?

Prepare your goals, symptoms, diagnoses, surgeries, allergies, current medications and supplements, recent labs if available, prior treatment response, pregnancy or fertility considerations, and questions about pharmacy sourcing, costs, side effects, refills, and follow-up.

Should the first visit discuss compounded versus FDA-approved medication?

Yes. Patients should understand whether the product is FDA-approved for the use, used off-label, compounded for an individualized prescription, or evidence-limited for the goal. Compounded medications are not FDA-approved finished drug products in the same way as approved brand-name drugs.

What are red flags during a first peptide therapy appointment?

Red flags include no licensed clinician review, no prescription process, research-use products sold for human treatment, guaranteed results, hidden pharmacy sourcing, vague total pricing, no side-effect plan, no follow-up path, or pressure to pay before eligibility is reviewed.